Lindbrook Capital, LLC Moderna, Inc. Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,272 shares of MRNA stock, worth $51,846. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,272

Previous 1,923 33.85%

Holding current value

$51,846

Previous $228,000 62.72%

% of portfolio

0.01%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$63.64 - $125.14 $41,429 - $81,466	-651 Reduced 33.85%	1,272 $85,000
Q2 2024 Jul 31, 2024	BUY	$101.21 - $166.61 $45,342 - $74,641	448 Added 30.37%	1,923 $228,000
Q1 2024 Apr 25, 2024	BUY	$85.37 - $115.44 $7,171 - $9,696	84 Added 6.04%	1,475 $157,000
Q4 2023 Jan 31, 2024	BUY	$69.51 - $104.43 $28,568 - $42,920	411 Added 41.94%	1,391 $138,000
Q3 2023 Oct 25, 2023	SELL	$96.41 - $126.61 $4,242 - $5,570	-44 Reduced 4.3%	980 $101,000
Q2 2023 Jul 28, 2023	BUY	$118.5 - $160.53 $15,405 - $20,868	130 Added 14.54%	1,024 $124,000
Q1 2023 Apr 26, 2023	SELL	$135.66 - $197.02 $18,178 - $26,400	-134 Reduced 13.04%	894 $137,000
Q4 2022 Jan 24, 2023	BUY	$118.38 - $210.04 $21,663 - $38,437	183 Added 21.66%	1,028 $0
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $4,250 - $6,990	-36 Reduced 4.09%	845 $100,000
Q2 2022 Aug 01, 2022	SELL	$117.13 - $176.59 $161,756 - $243,870	-1,381 Reduced 61.05%	881 $126,000
Q1 2022 Apr 21, 2022	BUY	$126.46 - $235.05 $18,716 - $34,787	148 Added 7.0%	2,262 $390,000
Q4 2021 Jan 18, 2022	BUY	$225.82 - $368.51 $383,442 - $625,729	1,698 Added 408.17%	2,114 $537,000
Q3 2021 Nov 05, 2021	BUY	$221.9 - $484.47 $7,322 - $15,987	33 Added 8.62%	416 $160,000
Q2 2021 Jul 27, 2021	BUY	$129.91 - $234.98 $3,117 - $5,639	24 Added 6.69%	383 $90,000
Q1 2021 Apr 28, 2021	BUY	$109.18 - $185.98 $2,620 - $4,463	24 Added 7.16%	359 $47,000
Q4 2020 Jan 27, 2021	BUY	$65.74 - $169.86 $9,861 - $25,479	150 Added 81.08%	335 $35,000
Q3 2020 Nov 03, 2020	BUY	$54.34 - $94.85 $7,009 - $12,235	129 Added 230.36%	185 $13,000
Q2 2020 Jul 27, 2020	BUY	$29.67 - $80.0 $593 - $1,600	20 Added 55.56%	56 $4,000
Q1 2020 Apr 22, 2020	BUY	$17.78 - $31.58 $640 - $1,136	36 New	36 $1,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Moderna, Inc. Transaction History